Evidence map›Paper›PMID 27376713›Full record

ArticleThe Journal of pathology2016

Monomeric C-reactive protein and inflammation in age-related macular degeneration.

Kathleen R Chirco, S Scott Whitmore, Kai Wang, Lawrence A Potempa, Jennifer A Halder, Edwin M Stone, Budd A Tucker, Robert F Mullins

Open access · greenAbstract read
In one paragraph

Article in The Journal of pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kathleen R ChircoThe Stephen A Wynn Institute for Vision Research, The University of Iowa, Iowa City, Iowa, USA.
S Scott WhitmoreThe Stephen A Wynn Institute for Vision Research, The University of Iowa, Iowa City, Iowa, USA.
Kai WangThe Stephen A Wynn Institute for Vision Research, The University of Iowa, Iowa City, Iowa, USA.
Lawrence A PotempaRoosevelt University College of Pharmacy, Schaumburg, Illinois, USA.
Jennifer A HalderThe Stephen A Wynn Institute for Vision Research, The University of Iowa, Iowa City, Iowa, USA.
Edwin M StoneThe Stephen A Wynn Institute for Vision Research, The University of Iowa, Iowa City, Iowa, USA.
Budd A TuckerThe Stephen A Wynn Institute for Vision Research, The University of Iowa, Iowa City, Iowa, USA.
Robert F MullinsThe Stephen A Wynn Institute for Vision Research, The University of Iowa, Iowa City, Iowa, USA. Robert-Mullins@uiowa.edu.
University of Iowa · USRoosevelt University · US

Funding

Choriocapillaris Protection and Replacement in AMDR01EY024605 · NEI · UNIVERSITY OF IOWA · PI Robert Foster Mullins, Budd A Tucker · 2014 to 2026
$4.6M
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM008629 · NIGMS · UNIVERSITY OF IOWA · PI EBERL, DANIEL F · 1997 to 2021
$4.1M
NEI NIH HHS R01 EY024605NIGMS NIH HHS T32 GM008629
6 · The paper itself

Abstract

Age-related macular degeneration (AMD) is a devastating disease characterized by central vision loss in elderly individuals. Previous studies have suggested a link between elevated levels of total C-reactive protein (CRP) in the choroid, CFH genotype, and AMD status; however, the structural form of CRP present in the choroid, its relationship to CFH genotype, and its functional consequences have not been assessed. In this report, we studied genotyped human donor eyes (n = 60) and found that eyes homozygous for the high-risk CFH (Y402H) allele had elevated monomeric CRP (mCRP) within the choriocapillaris and Bruch's membrane, compared to those with the low-risk genotype. Treatment of choroidal endothelial cells in vitro with mCRP increased migration rate and monolayer permeability compared to treatment with pentameric CRP (pCRP) or medium alone. Organ cultures treated with mCRP exhibited dramatically altered expression of inflammatory genes as assessed by RNA sequencing, including ICAM-1 and CA4, both of which were confirmed at the protein level. Our data indicate that mCRP is the more abundant form of CRP in human choroid, and that mCRP levels are elevated in individuals with the high-risk CFH genotype. Moreover, pro-inflammatory mCRP significantly affects endothelial cell phenotypes in vitro and ex vivo, suggesting a role for mCRP in choroidal vascular dysfunction in AMD. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Indexed as

AllelesCell MovementChoroidC-Reactive ProteinGene ExpressionHumansInflammationIntercellular Adhesion Molecule-1Macular DegenerationC-Reactive ProteinIntercellular Adhesion Molecule-1age-related macular degenerationchoroidC-reactive proteinICAM-1inflammationmicrovasculature

Identifiers

PMID27376713
PMCPMC5527328
OpenAlexW2506319752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.